Evidence map›Paper›PMID 23263009›Full record

ArticleAntimicrobial agents and chemotherapy2013

Apoptotic marker expression in the absence of cell death in staurosporine-treated Leishmania donovani.

Aude L Foucher, Najma Rachidi, Sarah Gharbi, Thierry Blisnick, Philippe Bastin, Iain K Pemberton, Gerald F Späth

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. SystematicFrontiers in chemistry · 2021
    Article
  2. Article
  3. Tocopherol biosynthesis inFEBS open bio · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Different apoptosis pathways inCell death discovery · 2018
    Article
  9. Article
  10. Observational
  11. Article
  12. AsteraceaeEvidence-based complementary and alternative medicine : eCAM · 2016
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Aude L FoucherInstitut Pasteur CNRS URA2581, Unité de Parasitology Moléculaire et Signalisation, Paris, France.
Najma Rachidi
Sarah Gharbi
Thierry Blisnick
Philippe Bastin
Iain K Pemberton
Gerald F Späth
Institut Pasteur · FRLaboratoire de Biologie Moléculaire et Cellulaire des Eucaryotes · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protozoan parasite Leishmania donovani undergoes several developmental transitions in its insect and vertebrate hosts that are induced by environmental changes. The roles of protein kinases in these adaptive differentiation steps and their potential as targets for antiparasitic intervention are only poorly characterized. Here, we used the generic protein kinase inhibitor staurosporine to gain insight into how interference with phosphotransferase activities affects the viability, growth, and motility of L. donovani promastigotes in vitro. Unlike the nonkinase drugs miltefosine and amphotericin B, staurosporine strongly reduced parasite biosynthetic activity and had a cytostatic rather than a cytotoxic effect. Despite the induction of a number of classical apoptotic markers, including caspase-like activity and surface binding of annexin V, we determined that, on the basis of cellular integrity, staurosporine did not cause cell death but caused cell cycle arrest and abrogated parasite motility. In contrast, targeted inhibition of the parasite casein kinase 1 (CK1) protein family by use of the CK1-specific inhibitor D4476 resulted in cell death. Thus, pleiotropic inhibition of L. donovani protein kinases and possibly other ATP-binding proteins by staurosporine dissociates apoptotic marker expression from cell death, which underscores the relevance of specific rather than broad kinase inhibitors for antiparasitic drug development.

Indexed as

Amino Acid SequenceAmphotericin BAnnexin A5Antiprotozoal AgentsApoptosisBenzamidesBiomarkersCasein Kinase ICell Cycle CheckpointsHumansImidazolesLeishmania donovaniMolecular Sequence DataPhosphorylcholinePhosphotransferasesProtein Biosynthesis4-(4-(2,3-dihydrobenzo(1,4)dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamideAmphotericin BAnnexin A5Antiprotozoal AgentsBenzamidesBiomarkersCasein Kinase IImidazolesmiltefosinePhosphorylcholinePhosphotransferasesProtein Kinase InhibitorsProtozoan ProteinsStaurosporine

Identifiers

PMID23263009
PMCPMC3591890
OpenAlexW2080748587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.